21 May 2013
Keywords: genentech, reports, solid, results, boosted, avastin, analysts
Article | 26 January 2009
US biotechnology giant Genentech reported solid figures for full-year 2008 in the shadow of a potential full takeover by Swiss majority
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 January 2009
20 May 2013
© 2013 thepharmaletter.com